1. Introduction {#sec1}
===============

Sulfasalazine used in the therapy of inflammatory bowel diseases, such as ulcerative colitis and Crohn\'s disease \[[@B1], [@B2]\]. Ingested sulfasalazine passes to the colon without being absorbed in intestine and is split into 5-aminosalicylic acid (5-ASA) and sulfapyridine by colonic bacteria \[[@B1], [@B2]\]. Most of 5-ASA is metabolized by *N*-acetyl-conjugation in the form of *N*-acetyl 5-aminosalicylic acid (5-AcASA) in the colonic epithelia, while sulfapyridine is quickly absorbed from the colon and metabolized in the liver \[[@B3]--[@B5]\]. It has been proposed that 5-ASA, the active moiety of sulfasalazine, exerts an antiinflammatory activity by inhibiting prostaglandin synthesis in colonic mucosa \[[@B6], [@B7]\]. Some reports have shown that 5-AcASA has a potency as an inhibitor of prostaglandin synthesis comparable to that of 5-ASA \[[@B7]\], and therapeutically active when administered by enema to patients with ulcerative colitis \[[@B8]\]. However, 5-AcASA formed in colonic epithelia is immediately secreted into mucosal lumen and excreted in feces \[[@B9]--[@B11]\]. Thus, 5-AcASA is considered the portion that has already exerted therapeutical action within the bowel tissue \[[@B1]--[@B3], [@B9]--[@B11]\]. Zhou et al. reported that 5-AcASA was exclusively transported from the basolateral to the apical direction using human colon-derived Caco-2 cells \[[@B11]\]. However, the mechanism underlying the cellular transport of 5-AcASA has not extensively elucidated. It is well known that flavonoids ([Figure 1](#fig1){ref-type="fig"}), plant-derived compounds, alter the function of efflux transporters such as P-glycoprotein, that is, present in epithelium cells \[[@B12]--[@B14]\]. Recently, several researchers reported the inhibitory interaction of flavonoids with multidrug resistance-associated proteins (MRPs) that are responsible for active secretion of pharmacologically relevant drugs \[[@B15]--[@B20]\]. In this study, the effect of flavonoids and transporter inhibitors on the cellular efflux of 5-AcASA that was intracellularly formed from 5-ASA was examined in Caco-2 cells. Certain flavonoids and MRPs inhibitors displayed strong potency in decreasing the preferential apical efflux of 5-AcASA and in increasing the cellular accumulation of 5-AcASA in Caco-2 cells.

2. Materials and Methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

Materials and chemical reagents were purchased from the following companies: Transwells from Corning Costar (Cambridge, MA, USA); tissue culture dishes from Becton Dickinson Com. (Falcon; USA); flavonoids from Funakoshi Co. (Tokyo, Japan); 5-ASA and quinidine from Sigma-Aldrich Com. (Japan); MK571 from Alexis Biochemicals (Lausen, Switzerland); mitoxantrone from LKT Laboratories (MA, USA); indomethacin and other chemicals used from Wako Pure Chemical Co. (Osaka, Japan); and the Develosil RPAQUEOUS C-30-UG-3 column (4.6 I.D. × 150 mm) from Nomura Chemical Co. (Aichi, Japan). Cyclosporin A was purchased from Sigma-Aldrich Com. and Wako Pure Chemical Co. 5-AcASA was synthesized by the reaction of 5-ASA with acetic anhydride, as described by other researchers \[[@B21]\].

2.2. Efflux of 5-AcASA from Caco-2 Cells {#sec2.2}
----------------------------------------

Caco-2 cells were purchased from the Riken (no. RCB0988) and used as previously described \[[@B22]\]. The cell line was cultured in Dulbecco\'s modified Eagle\'s medium containing 12% fetal calf serum and penicillin-streptomycin-amphotericin B. The suspended cells were seeded on 6-well- polycarbonate Transwell inserts (0.4 *μ*m mean pore size, 4.7 cm^2^ growth area) at a density of 5 × 10^4^ cells/dish, and then placed in an incubator in an atmosphere of 5% CO~2~--95% air at 37°C. The Caco-2 cells in the Transwell were grown for 3 weeks in Dulbecco\'s modified Eagle\'s medium containing fetal calf serum. The monolayers with transepithelial electric resistance of more than 250 Ω cm^2^ were used for transport studies. 5-ASA in a stock solution at 50 mM was added to the apical chamber at a final concentration of 200 *μ*M after 10 minutes of the addition of flavonols. After incubation for 2 and 4 hours at 37°C, 50 *μ*L of the medium from both of the chambers was mixed with 50 *μ*L of 0.5 M perchloric acid.

2.3. Cellular Accumulation of 5-AcASA {#sec2.3}
-------------------------------------

Caco-2 cell line at passage of 40 was used for the experiments. The suspended cells in Dulbecco\'s modified Eagle\'s medium containing 12% fetal calf serum and penicillin-streptomycin-amphotericin B were seeded on 35 mm plastic culture dishes at a density of 5 × 10^4^ cells/dish. After seeding, the cells were cultured in a 37°C incubator under 5% CO~2~--95% air at 37°C for two weeks until the cells were fully differentiated into confluent enterocyte-like monolayers. Flavonoids, 5-ASA and other chemicals were dissolved in dimethyl sulfoxide and added to the medium at definite concentrations, with the final concentration of dimethyl sulfoxide about 1%. After incubation for 2 hours, the cell monolayers were washed twice with Hanks balanced solution and harvested. The adequate volume of the medium and cell suspensions was treated with the same volume of 0.5 M perchloric acid.

2.4. HPLC Analysis {#sec2.4}
------------------

Chromatographic separation and quantitative determination were carried out according to the HPLC analytical methods described previously \[[@B23]\]. A 0.1 mL aliquot of perchloric acid-treated sample was neutralized with 25 *μ*L of 1 M NaOH solution and 25 *μ*L of 0.5 M Tris-HCl buffer (pH 7.4), and the total volume was adjusted to 0.5 mL with HPLC elution solvent. A 50 *μ*L aliquot of sample was injected onto a Develosil C-30-UG-3 (4.6 I.D. × 150 mm) column adjusted to 40°C, and 5-AcASA was separated by solution with a mixture of acetonitrile (4%) and 20 mM phosphate buffer (pH 5.0 solution) using a CCPD HPLC system equipped with an FS-8020 fluorescence detector (Tosoh Co., Japan). The flow rate of the mobile phase was 1.0 mL/min, and elution of 5-ASA and 5-AcASA was monitored at a fluorescence excitation wavelength of 310 nm and an emission wavelength of 480 nm. 5-ASA and 5-AcASA were eluted at 2.7 and 11.5 minutes, respectively. The quantitative determination of 5-AcASA was based upon the integration of fluorescence peak areas.

2.5. Statistical Analysis {#sec2.5}
-------------------------

The data in figures are given as the mean ± S.D. of four to five experiments. Differences among the mean values were assessed by Dunnett\'s test using Stat-100 (BIOSOFT, UK) or Student\'s *t*-test. A *P* value of \< 0.05 was considered significant.

3. Results {#sec3}
==========

The incubation of Caco-2 cells with 5-ASA formed only one peak of 5-ASA metabolite, which was identified as 5-AcASA by the same retention time as the synthesized standard in HPLC. The *N*-acetyl-conjugative reaction of 5-ASA in Caco-2 cells was saturated above 1 mM of 5-ASA. The effect of flavonols and inhibitors of transporters on 5-AcASA efflux was examined using Caco-2 cell monolayers grown in Transwells which contained 1.5 and 2.6 mL Dulbecco\'s modified Eagle\'s medium in the apical and basolateral chambers, respectively. 5-ASA was loaded at 200 *μ*M in the apical chamber and 5-AcASA discharged from both of the apical and basolateral sites was measured. After 1, 2, and 4-hour incubation, amounts of 5-AcASA were 1.01, 2.05, and 5.04 nmoles in the apical chamber and 0.19, 0.29, and 0.62 nmoles in the basolateral chamber, respectively ([Table 1](#tab1){ref-type="table"}). The apical efflux of 5-AcASA was 5.32, 7.07, and 8.13-fold higher than the basolateral efflux at 1, 2, and 4-hour incubation, respectively. When fisetin and quercetin (100 *μ*M) were added with 5-ASA to Caco-2 cells, the apical efflux of 5-AcASA decreased remarkably ([Table 1](#tab1){ref-type="table"}). The basolateral efflux of 5-AcASA rather increased in the presence of such flavonols. The ratios for the apical to the basolateral efflux of 5-AcASA actually decreased to 0.52 and 0.68 at 1 hour, 0.77 and 0.85 at 2 hours, and 0.92 and 1.05 at 4-hour incubation, in the presence of fisetin and quercetin, respectively. Morin had a weaker effect than fisetin and quercetin. MK571, a MRPs inhibitor, showed a similar effect to quercetin; however, quinidine, a P-glycoprotein inhibitor, had no effects.

[Figure 2](#fig2){ref-type="fig"}shows the time course of the amount of 5-AcASA in the cells, medium, and their total (cells plus medium), and the percentage of cellular accumulation of 5-AcASA at 1, 2, and 4-hour incubation in the presence of flavonols (100 *μ*M) with 5-ASA (200 *μ*M) in Caco-2 cells grown in tissue culture dishes. 5-AcASA was formed at the rate of 4 nmol/h/1 × 10^6^ cells during a 4 h-incubation period in the control cells. Flavonoids are potent inhibitors of *N*-acetyltransferase \[[@B23]\]. Fisetin remarkably decreased the formation of 5-AcASA from 5-ASA in Caco-2 cells. Furthermore, a large amount of 5-AcASA was found in the cells treated by quercetin. The amount of 5-AcASA inside the control cells was 12 percent of the total 5-AcASA at a 1 h-incubation and decreased to 6.3 and 3.2 percents at 2 and 4-hour incubation, respectively. The cellular accumulation rate increased by several-fold than that of the control cells by quercetin and fisetin, and increased slightly by morin during a 4 h-incubation period.[Figure 3](#fig3){ref-type="fig"}shows the amount of 5-AcASA in the cells and medium in the presence of various flavonoids at a 2 h-incubation. Flavonoids that lack a hydroxyl substitution at the C5 position on the A-ring had a strong inhibitory effect on the *N*-acetyl-conjugation of 5-ASA. The total 5-AcASA formed in the presence of fisetin, 7,3′,4′-OH flavone, 7,4′-OH flavone and geraldol decreased to 16.3, 23.3, 54.3, and 68.3 percents of that of the control cells, respectively. Furthermore, most of flavonols and flavones caused an abundant cellular accumulation of 5-AcASA inside the cells. The cellular 5-AcASA accumulation was 52.7 percent of the total formed in the presence of quercetin, the most effective one among flavonoids tested ([Table 2](#tab2){ref-type="table"}). Flavonoids that lack a C2-3 double bond or a carboxyl group at the C4 position on the C-ring, such as catechins and taxifolin, had no effects. The structural feature required for the potent effect on the cellular 5-AcASA accumulation was a presence of hydroxyl group on the B-ring of flavone structure. The effect of inhibitors or substrate of transporters on the cellular 5-AcASA accumulation was compared with flavonols at a 2 h-incubation with 200 *μ*M of 5-ASA in Caco-2 cells ([Figure 4](#fig4){ref-type="fig"}). MK-571 and indomethacin, MRPs inhibitors \[[@B24]--[@B26]\], increased in concentration-dependent manner the cellular 5-AcASA accumulation, while they did not affect the formation of 5-AcASA. MK-571 was more effective than indomethacin and showed equivalent efficacy to quercetin and fisetin. On the other hand, qunidine, a P-glycoprotein inhibitor, and cyclosporine A, an inhibitor of both P-glycoprotein and MRPs \[[@B27], [@B28]\], did not affect the cellular 5-AcASA accumulation. Mitoxantrone, a breast cancer resistance protein (BCRP) substrate \[[@B29]\], had no effects either at the concentration of 20 *μ*M (data not shown).

4. Discussion {#sec4}
=============

5-AcASA that was formed from 5-ASA in the interior of cells was discharged preferentially to the apical direction compared to the basolateral direction in Caco-2 cells grown in Transwells. Quercetin and fisetin remarkably decreased the apical efflux of 5-AcASA, while morin did with a less potency. The amount of 5-AcASA in Caco-2 cells and the medium was measured during a 4 h-incubation with 5-ASA in the presence of such flavonols. Flavonoids are effective inhibitors of *N*-acetyl-conjugation of 5-ASA in rat liver cytosol preparation \[[@B23]\]. Fisetin, in particular, exhibited strong inhibitory activity on 5-AcASA formation in Caco-2 cells. Thus, the inhibition of 5-AcASA formation is likely to contribute largely to the decrease in the 5-AcASA efflux in the case of fisetin. However, quercetin showed a much weaker inhibitory effect on the 5-AcASA formation than fisetin. Surprisingly, the formed 5-AcASA was found to be accumulated inside the cells treated by flavonols. For quercetin, the cellular accumulation of 5-AcASA coincides with the decrease in 5-AcASA apical efflux. An increase in the basolateral efflux of 5-AcASA during an incubation of Transwells is probably due to the extensive cellular accumulation of 5-AcASA particularly in quercetin-treated cells.

A large group of flavonoids were examined for their inhibitory effects on the 5-AcASA formation as well as their promoting effects on the cellular 5-AcASA accumulation. A key chemical determinant necessary for exerting the strong inhibitory effect on the *N*-acetyl-conjugation of 5-ASA was a lack of hydroxyl substitution at the C5 position on the A-ring of flavone structure such as fisetin and 7,3′,4′-OH favone. On the other hand, the structural requirement for the promoting effect on cellular 5-AcASA accumulation was a presence of hydroxyl substitution at the C3′ or C4′ position on the B-ring of flavone structure. Therefore, the inhibition of 5-AcASA formation and the promotion of cellular 5-AcASA accumulation by flavonoids seem to be caused by different mechanisms.

The results mentioned above suggest that 5-AcASA is pumped out by an active efflux transporter located on the apical membrane and certain flavonoids appear to play an important replacing role in the apical-directed transport of 5-AcASA in Caco-2 cells. Flavonoids are well-known modulators of the cellular transport of various substances mediated by P-glycoprotein which is localized on apical membranes in polarized cells \[[@B12]--[@B14]\]. Recently, several researchers reported the interaction of flavonoids with MRPs transporters. Walgren et al. reported that the efflux of quercetin 4′-beta-glucoside across Caco-2 cell monolayers was mediated by MRP2 \[[@B24]\]. Van Zanden et al. studied on the inhibitory effect of quercetin on MRPs pump-mediated efflux of calcein and vincristine, well-known MRPs substrates, in the MRP1 and MRP2 transfected MDCK cells \[[@B18]--[@B20]\]. They mentioned that MRP2 displayed higher selectivity for flavonoid-type inhibition than MRP1. Phase `II` metabolites of various drugs conjugated to glutathione, glucuronate, or sulfate are generally considered to be transported by MRPs-like transporters \[[@B30]--[@B32]\]. MRPs were characterized as the canalicular multispecific organic anion transporters that function in terminal secretion into bile canaliculus of endo- and xenobiotics such as acetaminophen metabolites, bilirubin glucuronides, 2,4-dinitrophoenyl-S-glutathione, 17*β*-glucuronosyl estradiol, and 4-methylumbelliferyl glucuronide that are conjugated in hepatocytes \[[@B33]--[@B35]\]. The transcellular transport of acetyl-conjugated 5-ASA from the basolateral site to the apical site in Caco-2 cell was first reported by Zhou et al. \[[@B11]\]. However, the transporter-mediated efflux of 5-AcASA has not been investigated thoroughly. To address the interest in involvement of transporters that are responsible for the 5-AcASA apical efflux in Caco-2 cells, several inhibitors of transporters were examined for their suppressing effect on the 5-AcASA apical efflux and promoting effect on the cellular 5-AcASA accumulation. MK571 and indomethacin, inhibitors of MRPs had similar effects to flavonoids. Quinidine, a P-glycoprotein inhibitor, and Cyclosporine A, an inhibitor of P-glycoprotein and MRPs \[[@B27], [@B28]\], showed no effects. Absence of inhibitory activity of Cyclosporine A may be explained by substrate specificity of 5-AcASA for MRPs. Mitoxantrone, a substrate of BCRP \[[@B29]\], had no effects either. These results suggest that 5-AcASA is possibly pumped out by an MRPs-like transporter and certain flavonoids inhibit their efflux-pump activity in Caco-2 cells.

Flavonoids are part of the human diet and possess many health benefits with low toxicity \[[@B36], [@B37]\]. However, flavonoids are poorly absorbable compounds from the digestive tract in vertebrates \[[@B38], [@B39]\]. When quercetin was given p.o. to the rats (630 mg/kg), approximately 20% of the total dose was absorbed from the digestive tract, more than 30% was decomposed in the intestinal microflora, and approximately 30% was excreted unchanged in the feces during 72 hours \[[@B38]\]. After a single oral dose of quercetin in humans (4 g), approximately 53% of the dose was recovered unchanged in the feces. Thus it was concluded that 1% of the original 4 g dose of quercetin was absorbed \[[@B39]\]. In this study, flavonoids were added at the concentration range from 20 to 100 *μ*M only into the apical compartment of Caco-2 cells in Transwells that faces to intestinal lumen in vivo. A high luminal level around 100 *μ*M of flavonoids is expected to be achieved with a single oral administration of a few hundred mg of flavonoids in humans.

5-ASA, an active moiety of sulfasalazine, is immediately secreted into the luminal side from intestinal epithelia following extensive *N*-acetyl-conjugation, and is finally excreted into feces \[[@B3]--[@B5]\]. Zhou et al. \[[@B11]\] reported that at luminal levels below 200 *μ*g/mL (concentrations that are typically achieved by controlled release dosage forms), intestinal secretion of 5-AcASA accounts for more than 50% of the total 5-ASA elimination. Thus, 5-AcASA has been considered to be therapeutically nonactive portion \[[@B1]--[@B3], [@B9]--[@B11]\]. However, 5-AcASA has still antiinflammatory potential if the drug retains within the intestinal tissues \[[@B8]\]. The efficacy of 5-ASA therapy correlates with tissue delivery of 5-ASA, that is, determined by *N*-acetylation and cellular discharge. The present study showed that certain flavonoids have the inhibitory effect on *N*-acetyl-conjugation of 5-ASA and the suppressive effect on the 5-AcASA apical efflux in Caco-2 cells. Viewed in this light, both of these effects of flavonoids seem to be desirable in the treatment of inflammatory bowel diseases, since coadministration of flavonoids with 5-ASA is expected to increase the tissue levels of 5-ASA and 5-AcASA in intestine.

![Structure of flavonoids.](JBB2009-467489.001){#fig1}

![(a) The time course curve of *N*-acetyl 5-aminosalicylic acid in Caco-2 cells, (b) the medium and (c) the total, and (d) the cellular accumulation percent. Caco-2 cells grown in tissue culture dishes were incubated with 200 *μ*M 5-ASA for 1, 2, and 4 hours in the absence (![](JBB2009-467489.005.jpg)) and the presence of quercetin (![](JBB2009-467489.006.jpg)), fisetin (![](JBB2009-467489.007.jpg)), and morin (![](JBB2009-467489.008.jpg)) at the concentration of 100 *μ*M. Cell 5-AcASA (%): (cells/cells plus medium) × 100. Each point represents the mean ± SD of four to five experiments. Significant difference from control \**P* \< .05, \*\**P* \< .01.](JBB2009-467489.002){#fig2}

![The amount of *N*-acetyl 5-aminosalicylic acid in Caco-2 cells and the medium. Caco-2 cells grown in tissue culture dishes were incubated with 200 *μ*M 5-ASA for 2 hours in the presence of flavonoids at the concentration of 100 *μ*M. 5-ASA in cells (Closed column), 5-ASA in medium (Open column). Each bar represents the mean ± SD of four to five experiments. Significant difference from control \**P* \< .05, \*\**P* \< .01.](JBB2009-467489.003){#fig3}

![The effect of flavonols and transpoter inhibitors on the cellular accumulation of *N*-acetyl 5-aminosalicylic acid in Caco-2 cells. Caco-2 cells grown in tissue culture dishes were incubated with 200 *μ*M 5-ASA for 2 hours in the presence of flavonols and transporter inhibitors at the concentration of 100 *μ*M. Cellular accumulation percent : (cells/cells plus medium) × 100. Each bar represents the mean ± SD of four to five experiments. Significant difference from control \**P* \< .05, \*\**P* \< .01.](JBB2009-467489.004){#fig4}

###### 

The effect of flavonols and transporter inhibitors on the apical and basolateral efflux of *N*-acetyl 5-aminosalicylic acid in Caco-2 cells. Caco-2 cells grown in Transwells were incubated with 200 *μ*M 5-ASA for 1, 2, and 4 hours in the presence of flavonols and transporter inhibitors at the concentration of 100 *μ*M. Api: apical efflux of 5-AcASA, Baso: basolateral efflux of 5-AcASA. Each value represents the mean ± SD of four to five experiments.

                              Control           Fisetin           Quercetin         Morin             MK571             Quinidine
  ------------- ------------- ----------------- ----------------- ----------------- ----------------- ----------------- -------------
  1hr           Api (nmol)    1.01 ± 0.14       0.16 ± 0.06\*\*   0.32 ± 0.07\*\*   0.87 ± 0.03       0.47 ± 0.13\*\*   0.91 ± 0.16
  Baso (nmol)   0.19 ± 0.02   0.31 ± 0.09\*\*   0.47 ± 0.08\*\*   0.43 ± 0.01\*\*   0.45 ± 0.04\*\*   0.18 ± 0.03       
  Api/Baso      5.32 ± 0.38   0.52 ± 0.11\*\*   0.68 ± 0.06\*\*   2.02 ± 0.04\*\*   1.04 ± 0.19\*\*   5.06 ± 0.21       
                                                                                                                        
  2hr           Api (nmol)    2.05 ± 0.28       0.36 ± 0.13\*\*   0.80 ± 0.21\*\*   1.64 ± 0.15       1.05 ± 0.05\*\*   1.96 ± 0.59
  Baso (nmol)   0.29 ± 0.04   0.47 ± 0.11\*\*   0.94 ± 0.07\*\*   0.66 ± 0.06\*\*   0.70 ± 0.03\*\*   0.28 ± 0.07       
  Api/Baso      7.07 ± 0.19   0.77 ± 0.16\*\*   0.85 ± 0.16\*\*   2.48 ± 0.04\*\*   1.50 ± 0.11\*\*   7.00 ± 0.18       
                                                                                                                        
  4hr           Api (nmol)    5.04 ± 0.61       0.89 ± 0.25\*\*   2.16 ± 0.35\*\*   3.62 ± 0.94       2.30 ± 0.22\*\*   4.61 ± 0.72
  Baso (nmol)   0.62 ± 0.08   0.97 ± 0.21\*\*   2.05 ± 0.17\*\*   1.15 ± 0.20\*     1.14 ± 0.09\*\*   0.59 ± 0.10       
  Api/Baso      8.13 ± 0.27   0.92 ± 0.16\*\*   1.05 ± 0.23\*\*   3.15 ± 0.10\*\*   2.02 ± 0.11\*\*   7.81 ± 0.06       

Significant difference from control \**P* \< .05, \*\**P* \< .01.

###### 

The cellular accumulation percent of in *N*-acetyl 5-aminosalicylic acid Caco-2 cells. Caco-2 cells grown in tissue culture dishes were incubated with 200 *μ*M 5-ASA for 2 hours in the presence of flavonoids at the concentration of 100 *μ*M. Cellular accumulation percent: (cells/cells plus medium) × 100. Each value represents the mean ± SD of four to five experiments.

  Flavonoids          Cellular accumulation (%)   Flavonoids            Cellular accumulation (%)
  ------------------- --------------------------- --------------------- ---------------------------
  Control             5.5 ± 0.8                   7,3′,4′- OH flavone   38.7 ± 4.2\*\*
  Epicatechin         5.7 ± 0.3                   Diosmetin             41.8 ± 2.4\*\*
  Epigallocatechin    5.8 ± 0.3                   Fisetin               42.7 ± 1.2\*\*
  Taxifolin           6.9 ± 0.6                   7,4′-OH flavone       42.8 ± 4.5\*\*
  5-OH flavone        9.2 ± 0.2\*\*               Kaempferol            43.1 ± 0.7\*\*
  Morin               9.9 ± 0.3\*\*               Isorhamnetin          45.4 ± 4.1\*\*
  3-OH flavone        17.4 ± 0.9\*\*              Apigenin              45.7 ± 2.3\*\*
  7-OH flavone        20.1 ± 3.8\*\*              Geraldol              50.2 ± 1.1\*\*
  Galangin            21.3 ± 3.1\*\*              Luteolin              50.7 ± 3.2\*\*
  Chrysin             31.7 ± 3.5\*\*              Quercetin             52.7 ± 2.5\*\*
  3′,4′-OH flavones   36.7 ± 3.6\*\*                                    

Significant differences from control \**P* \< .05, \*\**P* \< .01.

[^1]: Recommended by Mostafa Z. Badr
